Navigation Links
Cooling treatment after cardiac arrest is cost-effective, Penn study shows
Date:8/15/2009

(PHILADELPHIA) A brain-preserving cooling treatment called therapeutic hypothermia is a cost-effective way to improve outcomes after out-of-hospital cardiac arrest, which claims the lives of more than 300,000 people each year in the United States and leaves thousands of others neurologically devastated. The treatment, which lowers body temperature to prevent damage to the brain and other major organs when blood flow is restored to the body following cardiac arrest, is considered a good value when compared to many other accepted and widely utilized medical treatments, including dialysis for kidney failure or complex heart surgeries, according to new University of Pennsylvania School of Medicine research published this week in Circulation: Cardiovascular Quality and Outcomes.

"Having already established that hypothermia improves neurological outcomes after cardiac arrest, we now know that the therapy is also a good use of health care resources," says lead author Raina M. Merchant, MD, MS, an emergency physician and Robert Wood Johnson Clinical Scholar at Penn Medicine. "We hope our findings will help more hospitals and insurers to adopt cooling protocols and help more survivors return to productive lives."

Despite national recommendations established in 2005 calling for out-of-hospital cardiac arrest patients to be treated with hypothermia when they remain comatose after resuscitation, many hospitals still don't offer the intervention. Among barriers to its use: Concerns about its cost, and difficulty coordinating the interdisciplinary resources and staff needed to employ the treatment. Merchant and her colleagues used a complex mathematical design to measure quality-adjusted survival after cardiac arrest, cost of hypothermia equipment and treatment, and cost of post-hospital discharge care. Factors affecting costs included additional nursing care required during cooling treatment, extra time spent in the intensive care unit and post
'/>"/>

Contact: Holly Auer
holly.auer@uphs.upenn.edu
215-200-2313
University of Pennsylvania School of Medicine
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Novel Cooling Therapy May Have Aided Injured Football Player
2. Skin Cooling After Laser Treatment Could Leave Marks
3. Consortium Health Plans Cuts Down on Power Usage and Cooling in Its Data Center Using ONStors Green Clustered NAS Solution
4. Cardium Announces InnerCools Endovascular Cooling to be Featured on Science Channels Series Cool Stuff: How It Works
5. Cooling May Not Help Injured Brains in Children
6. Late-breaking results of clinical trial on therapeutic endovascular cooling reported at TCT 2008
7. Cardium Reports on New York Citys Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients
8. BeneChill Launches European Study of Intra-Arrest Cooling
9. Top Neurology Programs Control Fever with Arctic Sun Cooling Technology
10. St. Josephs Healthcare System Becomes First Hospital in the Region to Implement Pre-Hospital Therapeutic Cooling to Save the Lives of Cardiac Arrest Patients
11. Chill Cooling Towels Introduces Instant Relief for Hot Flashes and Night Sweats
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... PrettySkin4Less announces it is stocking up with ... top skin care manufacturer EMINENCE to meet customer demands. ... and active organic ingredients to promote actual change rather ... products offer. For this reason it’s not hard to ... like products that do what they say they will ...
(Date:6/19/2013)... 2013 Strict rules for ... Orriant is launching a new tool to help ... with regulations. New HHS regulations will soon ... if their employer offers outcome-based, health-contingent, compliant wellness ... with these standards for nearly a decade. Orriant ...
(Date:6/19/2013)... New York, New York (PRWEB) June 19, 2013 ... involving pancreatitis and pancreatic cancer continue to mount in ... the U.S. Food & Drug Administration (FDA) recently held ... other diabetes drugs known as incretin mimetics. According ... may seek additional data from the makers of Januvia ...
(Date:6/19/2013)... In what is believed to be the largest follow-up ... hereditary dystonia a movement disorder that can cause ... report good success rates and lasting benefits. , Michele ... at Cedars-Sinai Medical Center,s Department of Neurology, and Ron ... at Beth Israel Deaconess Medical Center in Boston, published ...
(Date:6/19/2013)... disparities between minority and white clients in success ... these disparities vary widely from state to state. ... states there,s something amiss," says Stephan Arndt, Ph.D., ... strong racial and ethnic disparities for people in ... successfully, and those disparities are something we need ...
Breaking Medicine News(10 mins):Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3
... , TUESDAY, Dec. 14 (HealthDay News) -- ... genetic mutations associated with adrenal gland tumors by identifying ... affect the adrenal gland, which is located above the ... can also be cancerous -- cause the adrenal gland ...
... R.I. [Brown University] Brown University sociologists have ... about risky sexual behavior among Ethiopian teenagers and ... Simple, portable, low-cost, and low-tech, the group,s new ... and confidentially during face-to-face interviews. Professors of sociology ...
... Dec. 14 (HealthDay News) -- Two reports from the U.S. ... is hitting young and older Americans across the economic,spectrum. ... and Prevention, released the reports on Tuesday. Looking at ... data from 1988 to 1994 and from 2005 to 2008, ...
... Dec. 14, 2010 Cancer Research Institute, Inc. (CRI), ... the science of tumor immunology and foster the discovery ... the Cancer Vaccine Acceleration Fund (CVAF), a new model ... with the Ludwig Institute for Cancer Research Ltd (LICR) ...
... French . , MONTREAL, December 14, 2010 The ... learn to recognize the sound of their parents, voice and the ... parents and newborns admitted to the intensive care unit can be ... , Jan Lariviere, a nurse in the neonatal clinic and the ...
... Gardner HealthDay Reporter , TUESDAY, Dec. 14 (HealthDay ... the most from health-care reform, a new report shows. ... the elimination of restrictions on people with preexisting conditions, while ... subsidized coverage through health insurance exchanges -- are slated for ...
Cached Medicine News:Health News:New survey device gets better information on teenage sexual behavior 2Health News:New survey device gets better information on teenage sexual behavior 3Health News:Obesity Rising Across All Income Levels: CDC 2Health News:Cancer Research Institute launches Cancer Vaccine Acceleration Fund 2Health News:Cancer Research Institute launches Cancer Vaccine Acceleration Fund 3Health News:Cancer Research Institute launches Cancer Vaccine Acceleration Fund 4Health News:Once upon a time in the Intensive Care Unit ... 2Health News:Report Finds Baby Boomers to Gain Most From Health Care Reform 2Health News:Report Finds Baby Boomers to Gain Most From Health Care Reform 3
(Date:6/19/2013)... 2013 The American Association for Homecare (AAHomecare), along ... , announced today the filing of a lawsuit ... , asking that the scheduled July 1 expansion of ... (DME) be stopped because of serious licensing irregularities. ... (HHS) Secretary Kathleen Sebelius as the defendant. ...
(Date:6/19/2013)... 19, 2013 Amgen is pleased to announce the ... , Canada and Puerto ... Amgen Award for Science Teaching Excellence (AASTE). Now in its ... through 12th grade level who have an outstanding ability to ... With a long-standing commitment to science education, Amgen established the ...
(Date:6/19/2013)... 2013 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... England Journal of Medicine ( NEJM ) published ... investigational oral Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in ... lymphocytic lymphoma (SLL). Ibrutinib was shown to be safe ... even in patients who were at high-risk due to ...
Breaking Medicine Technology:AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 2Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6
... Texas and KOLN, Germany, June 8, 2011 Luminex ... der Stadt Koln, Institute of Pathology and Institute for ... Pathogen Panel (GPP) is being used successfully as a ... suspected of having an E. coli infection.  This includes ...
... Company (NYSE: LLY ) today announced that ... California ruled in Lilly,s favor, vacating a temporary restraining ... a preliminary injunction that sought to impose restrictions on ... recently filed litigation involving the two companies, diabetes collaboration ...
Cached Medicine Technology:Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis 2Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis 3Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis 4U.S. District Court Rules in Favor of Lilly in Amylin Litigation 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: